{
  "docId": "019dd923-5ddf-7308-8fca-0e5cf0e1ad99",
  "docSlug": "66e1021b86be5625",
  "documentTitle": "Global pharma winners – focus and efficiency matter",
  "authorId": "RolandBerger",
  "authorName": "Roland Berger",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "portrait",
  "aspectRatio": 0.707,
  "pageNumber": 7,
  "pageCount": 11,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "case_study",
  "function": "illustrate_case",
  "density": "dense",
  "nDataPoints": 10,
  "notes": "The slide combines a framework of four winning characteristics with a specific company case study and supporting data charts on disease focus and ESG performance.",
  "elementsJson": [
    "icon_grid",
    "paragraph",
    "bar_chart_stacked",
    "bar_chart_vertical"
  ],
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5ddf-7308-8fca-0e5cf0e1ad99/7",
  "deckHref": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99",
  "deckJsonHref": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99.json",
  "deckAnchorHref": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99#slide-7",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Winning companies share four characteristics measured by key performance indicators.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd951-e58d-7080-a16c-2447ebeedfc2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.2,
        "x": 0.52,
        "y": 0.062
      },
      "kind": "chart",
      "text": "Winners often focus on specific disease areas",
      "attrs": null,
      "subkind": "bar-stacked",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "10669427-36d9-4e0c-9965-59633cd6415b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.2,
        "x": 0.76,
        "y": 0.062
      },
      "kind": "chart",
      "text": "Winners score better in ESG",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "569df73a-e999-4118-a41e-14329f3ae28a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.45,
        "x": 0.05,
        "y": 0.1
      },
      "kind": "framework",
      "text": "Winning companies share four characteristics",
      "attrs": null,
      "subkind": "instance",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5ee20363-d654-461b-ad04-d1e39a3e3c1a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "EBITDA margin: 40%",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd951-e58d-7080-a16c-2a06d96e4900",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.45,
        "x": 0.52,
        "y": 0.1
      },
      "kind": "paragraph",
      "text": "Beyond achieving its growth targets, this player is also able to maintain a strong financial position...",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d0debce9-58de-4e1d-a839-74040c7d59ba",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.4,
        "x": 0.05,
        "y": 0.62
      },
      "kind": "paragraph",
      "text": "We analyzed a leading traditional biotech company highly focused on metabolic diseases, especially diabetes...",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d8cc01c3-994c-4faa-9dc6-e918ba7c3ada",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.4,
        "x": 0.05,
        "y": 0.46
      },
      "kind": "title",
      "text": "Case study – leadership, strategy, financial position and execution",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6524a228-a5ee-4038-8d31-0a5517dae0e9",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "mece-principle",
      "slug": null,
      "matchId": "505848c3-55cf-48f4-a931-921648937044",
      "evidence": "Four distinct characteristics of winning companies presented as a comprehensive set.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 8,
      "from": 7,
      "beatId": "21f7c979-2bb3-47ff-9b60-6ea8a09521aa",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Solution & Approach",
      "beatSlug": "consultants-gambit-solution-approach",
      "evidence": "The case study and key takeaways provide a solution and approach to addressing the problems and complications",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 10,
      "from": 3,
      "name": "Logic Chain",
      "slug": "01-logic-chain",
      "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
      "matchId": "90ec7d40-8102-4183-9181-4f6898343bb0",
      "evidence": "The document provides a clear and logical structure, connecting the situation and context to the solution and approach",
      "position": 0,
      "objective": "To demonstrate the logic and reasoning behind the efficiency measures",
      "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
      "confidence": 0.6,
      "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
    },
    {
      "to": 9,
      "from": 4,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "af7803fc-7fff-46d4-876f-a01233f27297",
      "evidence": "The document emphasizes the importance of efficiency measures in driving strong investor returns",
      "position": 1,
      "objective": "To highlight the cost of inaction and the importance of efficiency measures",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}